Market Cap 1.25B
Revenue (ttm) 75.13M
Net Income (ttm) -146.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -194.88%
Debt to Equity Ratio 0.00
Volume 11,104,399
Avg Vol 5,493,148
Day's Range N/A - N/A
Shares Out 305.38M
Stochastic %K 13%
Beta 1.02
Analysts Strong Sell
Price Target $10.14

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology
Sector: Healthcare
Phone: 604 559 9005
Address:
150 W 4th Avenue, Vancouver, Canada
tradersunion353
tradersunion353 May. 19 at 12:40 PM
$ABCL what are these clowns cheerleading and pumping when scam crashed 30% on phase 1 data?
0 · Reply
tranq19
tranq19 May. 19 at 9:03 AM
$ABCL wonder if we might see another Form 4 related to that 1.2M share buy around noon yesterday
0 · Reply
tranq19
tranq19 May. 19 at 8:42 AM
$ABCL John Montalbano, Director and former CEO of RBC Global Asset Management thought it was a good idea to pick up 20k shares at 4.77, 10% or so increase to position.
0 · Reply
tradersunion353
tradersunion353 May. 18 at 11:09 PM
$ABCL Dont fall for these paid pumpers.. especially clown Demamp Stock is bearish for 5 years even after phase 1 data stock did not perform.. What a junk POS.. looks like a scam to me
0 · Reply
tradersunion353
tradersunion353 May. 18 at 11:07 PM
$ABCL Overhyped underperforming Junk dropped from 5.60s to 4 dollars after phase 1 data Clowns are celebrating for what?
0 · Reply
Captain_Greed
Captain_Greed May. 18 at 10:56 PM
$EBS TRUMP ON EBOLA: I AM CONCERNED $NVAX $MRNA $ABCL
1 · Reply
8008track
8008track May. 18 at 10:26 PM
$ABCL generational company in the making
0 · Reply
TradeWinner
TradeWinner May. 18 at 9:27 PM
$ABCL ho hum again. Hold the course.
0 · Reply
freedomtrader6
freedomtrader6 May. 18 at 8:51 PM
Today’s portfolio action was intense. Inflation-hedged bond ETF ripping $AGRO, $BB, $ABCL, $LPTH all green—feels good watching this But here’s the reality: I hedged SPX two weeks ago. The recent parabolic move ate into a lot of profits. Portfolio at ATH, but not breaking through the all-time high—like standing at the summit but unable to climb higher. As my friend always says: being early can sometimes feel the same as being wrong. Felt that firsthand today. The market is testing patience—and showing who can really hold their ground.
0 · Reply
Ed_Ng
Ed_Ng May. 18 at 8:06 PM
$ABCL yeah. Left hand sold to right hands
0 · Reply
Latest News on ABCL
AbCellera price target raised to $8 from $7 at Stifel

2026-05-12T10:58:11.000Z - 7 days ago

AbCellera price target raised to $8 from $7 at Stifel


AbCellera Biologics Earnings Call Transcript: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Earnings Call Transcript: Q1 2026


AbCellera Biologics Earnings release: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Earnings release: Q1 2026


AbCellera Biologics Quarterly report: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Quarterly report: Q1 2026


AbCellera Biologics Slides: Q1 2026

May 11, 2026, 5:00 PM EDT - 7 days ago

AbCellera Biologics Slides: Q1 2026


AbCellera initiated with an Overweight at Cantor Fitzgerald

2026-05-05T10:36:31.000Z - 14 days ago

AbCellera initiated with an Overweight at Cantor Fitzgerald


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 20 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera Biologics Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 20 days ago

AbCellera Biologics Proxy statement: Proxy filing


AbCellera initiated with a Buy at JonesResearch

2026-04-09T20:10:26.000Z - 5 weeks ago

AbCellera initiated with a Buy at JonesResearch


AbCellera Biologics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Earnings Call Transcript: Q4 2025


AbCellera Biologics Annual report: Q4 2025

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Annual report: Q4 2025


AbCellera Biologics Earnings release: Q4 2025

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Earnings release: Q4 2025


AbCellera Biologics Slides: Q4 2025

Feb 24, 2026, 5:00 PM EST - 2 months ago

AbCellera Biologics Slides: Q4 2025


AbCellera reports FY25 EPS (49c) vs. (55c) last year

2026-02-24T21:15:21.000Z - 2 months ago

AbCellera reports FY25 EPS (49c) vs. (55c) last year


AbCellera Reports Full Year 2025 Business Results

Feb 24, 2026, 4:05 PM EST - 2 months ago

AbCellera Reports Full Year 2025 Business Results


AbCellera Biologics Slides: Corporate presentation

Jan 14, 2026, 7:00 AM EST - 4 months ago

AbCellera Biologics Slides: Corporate presentation


AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 10, 2025, 9:00 AM EST - 6 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors


AbCellera Biologics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings Call Transcript: Q3 2025


AbCellera Biologics Quarterly report: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Quarterly report: Q3 2025


AbCellera Biologics Earnings release: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Earnings release: Q3 2025


AbCellera Biologics Slides: Q3 2025

Nov 6, 2025, 5:00 PM EST - 6 months ago

AbCellera Biologics Slides: Q3 2025


AbCellera Reports Q3 2025 Business Results

Nov 6, 2025, 4:05 PM EST - 6 months ago

AbCellera Reports Q3 2025 Business Results


AbCellera appoints Sarah Noonberg as Chief Medical Officer

2025-09-10T13:20:54.000Z - 8 months ago

AbCellera appoints Sarah Noonberg as Chief Medical Officer

MGX


AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Sep 10, 2025, 9:07 AM EDT - 8 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer


AbCellera doses first participants in Phase 1 trial of ABCL575

2025-08-27T13:20:26.000Z - 9 months ago

AbCellera doses first participants in Phase 1 trial of ABCL575


AbCellera price target raised to $7 from $5 at BMO Capital

2025-08-08T13:26:29.000Z - 10 months ago

AbCellera price target raised to $7 from $5 at BMO Capital


AbCellera Biologics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings Call Transcript: Q2 2025


AbCellera Biologics Quarterly report: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Quarterly report: Q2 2025


AbCellera Biologics Earnings release: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Earnings release: Q2 2025


AbCellera Biologics Slides: Q2 2025

Aug 7, 2025, 5:00 PM EDT - 10 months ago

AbCellera Biologics Slides: Q2 2025


AbCellera Biologics Slides: Corporate Presentation

Aug 1, 2025, 7:00 AM EDT - 10 months ago

AbCellera Biologics Slides: Corporate Presentation


AbCellera assumed with an Outperform at Leerink

2025-07-07T10:40:33.000Z - 11 months ago

AbCellera assumed with an Outperform at Leerink


AbCellera Biologics Earnings Call Transcript: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q1 2025


AbCellera Biologics Earnings release: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q1 2025


AbCellera Biologics Quarterly report: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q1 2025


AbCellera Biologics Slides: Q1 2025

May 8, 2025, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q1 2025


AbCellera Reports Q1 2025 Business Results

May 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera Reports Q1 2025 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Earnings Call Transcript: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q4 2024


AbCellera Biologics Earnings release: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q4 2024


AbCellera Biologics Annual report: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Annual report: Q4 2024


AbCellera Biologics Slides: Q4 2024

Feb 27, 2025, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q4 2024


AbCellera Reports Full Year 2024 Business Results

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results


AbCellera Biologics Slides: FY 2025

Jan 15, 2025, 7:30 PM EST - 1 year ago

AbCellera Biologics Slides: FY 2025


AbCellera Biologics Earnings Call Transcript: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q3 2024


AbCellera Biologics Quarterly report: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Quarterly report: Q3 2024


AbCellera Biologics Earnings release: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Earnings release: Q3 2024


AbCellera Biologics Slides: Q3 2024

Nov 4, 2024, 5:00 PM EST - 1 year ago

AbCellera Biologics Slides: Q3 2024


AbCellera Reports Q3 2024 Business Results

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings Call Transcript: Q2 2024


AbCellera Biologics Quarterly report: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Quarterly report: Q2 2024


AbCellera Biologics Earnings release: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Earnings release: Q2 2024


AbCellera Biologics Slides: Q2 2024

Aug 6, 2024, 5:00 PM EDT - 1 year ago

AbCellera Biologics Slides: Q2 2024


AbCellera Reports Q2 2024 Business Results

Aug 6, 2024, 4:05 PM EDT - 1 year ago

AbCellera Reports Q2 2024 Business Results


AbCellera Biologics Earnings Call Transcript: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings Call Transcript: Q1 2024


AbCellera Biologics Quarterly report: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Quarterly report: Q1 2024


AbCellera Biologics Earnings release: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Earnings release: Q1 2024


AbCellera Biologics Slides: Q1 2024

May 7, 2024, 5:00 PM EDT - 2 years ago

AbCellera Biologics Slides: Q1 2024


AbCellera Reports Q1 2024 Business Results

May 7, 2024, 4:05 PM EDT - 2 years ago

AbCellera Reports Q1 2024 Business Results


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


AbCellera Biologics Proxy statement: Proxy Filing

Apr 29, 2024, 8:00 AM EDT - 2 years ago

AbCellera Biologics Proxy statement: Proxy Filing


tradersunion353
tradersunion353 May. 19 at 12:40 PM
$ABCL what are these clowns cheerleading and pumping when scam crashed 30% on phase 1 data?
0 · Reply
tranq19
tranq19 May. 19 at 9:03 AM
$ABCL wonder if we might see another Form 4 related to that 1.2M share buy around noon yesterday
0 · Reply
tranq19
tranq19 May. 19 at 8:42 AM
$ABCL John Montalbano, Director and former CEO of RBC Global Asset Management thought it was a good idea to pick up 20k shares at 4.77, 10% or so increase to position.
0 · Reply
tradersunion353
tradersunion353 May. 18 at 11:09 PM
$ABCL Dont fall for these paid pumpers.. especially clown Demamp Stock is bearish for 5 years even after phase 1 data stock did not perform.. What a junk POS.. looks like a scam to me
0 · Reply
tradersunion353
tradersunion353 May. 18 at 11:07 PM
$ABCL Overhyped underperforming Junk dropped from 5.60s to 4 dollars after phase 1 data Clowns are celebrating for what?
0 · Reply
Captain_Greed
Captain_Greed May. 18 at 10:56 PM
$EBS TRUMP ON EBOLA: I AM CONCERNED $NVAX $MRNA $ABCL
1 · Reply
8008track
8008track May. 18 at 10:26 PM
$ABCL generational company in the making
0 · Reply
TradeWinner
TradeWinner May. 18 at 9:27 PM
$ABCL ho hum again. Hold the course.
0 · Reply
freedomtrader6
freedomtrader6 May. 18 at 8:51 PM
Today’s portfolio action was intense. Inflation-hedged bond ETF ripping $AGRO, $BB, $ABCL, $LPTH all green—feels good watching this But here’s the reality: I hedged SPX two weeks ago. The recent parabolic move ate into a lot of profits. Portfolio at ATH, but not breaking through the all-time high—like standing at the summit but unable to climb higher. As my friend always says: being early can sometimes feel the same as being wrong. Felt that firsthand today. The market is testing patience—and showing who can really hold their ground.
0 · Reply
Ed_Ng
Ed_Ng May. 18 at 8:06 PM
$ABCL yeah. Left hand sold to right hands
0 · Reply
JennyRowes
JennyRowes May. 18 at 7:21 PM
$ABCL price has been pinned all day. somebody big is buying.
1 · Reply
DeMampCamp
DeMampCamp May. 18 at 4:04 PM
$ABCL What a dumpster fire, look for the 50ma to be tested and hope that we bounce there or it's likely headed back down to the low $3S
4 · Reply
Ed_Ng
Ed_Ng May. 18 at 3:59 PM
$ABCL we are all knowing it's a scam after 6 years
1 · Reply
tradersunion353
tradersunion353 May. 18 at 3:59 PM
$ABCL Lots of fake longs., mostly spreading from x to stocktwsts. They keep saying holding 50K shares. dont fall for the paid pumpers.. Look ar the stock performance for last 5 years and after phase1 data
1 · Reply
tradersunion353
tradersunion353 May. 18 at 3:57 PM
$ABCL 35% drop after phase 1 data.. yes this not scam as per who are married to this stock
0 · Reply
bonecrack_benny
bonecrack_benny May. 18 at 2:01 PM
0 · Reply
Ckkung71
Ckkung71 May. 18 at 1:54 PM
$ABCL same, same but different
0 · Reply
8008track
8008track May. 18 at 11:56 AM
$ABCL I’ve gotten a ton of friends to look into this company. A few have purchased small amounts. One or two of them are considering buying healthy chunks (50k shares or more). These guys would most likely hold looong term.
0 · Reply
Rastafari
Rastafari May. 18 at 11:36 AM
$ABCL — Early premarket action looks strong, and the numbers are lining up well. Last week’s sell‑off felt completely irrational. With firms like Goldman Sachs and the Baker Brothers heavily invested, I’m inclined to trust the judgment of people who have far deeper access and insight than the average trader. On top of that, Carl has the majority of his own wealth tied to this company. The man is a proven genius who has assembled an A‑team around him. That kind of conviction speaks volumes. Long and strong.
0 · Reply
Stockingtrade
Stockingtrade May. 18 at 11:28 AM
$ABCL up 0.2 (~5%) in premarket trading. Does someone know something?
0 · Reply
DeMampCamp
DeMampCamp May. 18 at 11:15 AM
$ABCL Wow, massive volume in the first 13 mins of PM (over 740,000)
0 · Reply
Captain_Greed
Captain_Greed May. 18 at 7:33 AM
$ABCL Given a case in Vancouver what are the odds that this innovative Canadian biotech is already working on antibodies #hantavirus
0 · Reply